StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) income statement

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3088% above fair value
$286.20+2.66 (+0.94%)

Close on Nov 20, 2026Market cap $505.75BP/E 80.8Yield 2.32%

See a number that looks wrong?